12
DEC
2019
Northwest Biotherapeutics (OTCQB:NWBO) Further Expands Senior Management Team
Comments : Off
For Immediate Release on Thursday, December 12, 2019 Northwest Biotherapeutics (OTCQB:NWBO) Further Expands Senior Management Team Executive With Decades of Public and Private Company Experience Joins NW Bio As CFO BETHESDA, Md., December 12, 2019 – Northwest Biotherapeutics (OTCQB: NWBO)(“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it has further... Read More